Clinical Trial: Retrospective Chart Review Study of Korlym for the Treatment of ACTH Independent Cushing's Syndrome

Study Status: Enrolling by invitation
Recruit Status: Enrolling by invitation
Study Type: Observational

Official Title: Retrospective Chart Review Study of Korlym for the Treatment of ACTH Independent Cushing's Syndrome

Brief Summary: Chart review study to collect patient data from medical charts of patients who have been treated with Korlym® for the treatment of ACTH independent adrenal Cushing's Syndrome.

Detailed Summary: A retrospective, multi-center, chart review study to collect patient data from medical charts of patients who have been treated with Korlym® for the treatment of ACTH independent adrenal Cushing's Syndrome. Treatment with Korlym® will be a minimum 3 months in duration with follow-up of a minimum 3 months. Only sites that have been identified to have patients appropriate for this protocol will be invited to participate.
Sponsor: Corcept Therapeutics

Current Primary Outcome: Drug Utilization Patterns as assessed by chart review [ Time Frame: up to 4 years ]

The retrospective review would analyze the drug utilization patterns of patients treated with Korlym


Original Primary Outcome: Same as current

Current Secondary Outcome: Clinical Outcomes as assessed by chart review [ Time Frame: up to 4 years ]

The retrospective review would analyze outcomes measures (vitals, clinical assessments, etc) in patients treated with Korlym


Original Secondary Outcome: Same as current

Information By: Corcept Therapeutics

Dates:
Date Received: January 8, 2016
Date Started: October 2015
Date Completion: December 2017
Last Updated: February 14, 2017
Last Verified: February 2017